Phio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $30 | $0 |
Gross Profit | -1 | -34 | ||
EBITDA | -1,590 | -1,845 | -2,175 | |
EBIT | -1,846 | -2,209 | ||
Net Income | -1,524 | -1,846 | -2,154 | -1,895 |
Net Change In Cash | 0 | 0 | 30 | 0 |
Free Cash Flow | -1,360 | -1,777 | -2,011 | -2,370 |
Cash | 5,390 | 4,698 | 6,475 | 8,490 |
Basic Shares | 990 | 510 | 508 | 416 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4 |
Gross Profit | -6,332 | -193 | -192 | -183 |
EBITDA | -10,642 | -11,269 | -13,436 | -8,721 |
EBIT | -10,826 | -11,462 | -13,511 | -8,904 |
Net Income | -10,826 | -11,305 | -13,212 | -8,794 |
Net Change In Cash | 0 | 0 | 0 | 4 |
Cost of Revenue | 7,310 | |||
Free Cash Flow | -10,754 | -12,250 | -11,909 | -8,821 |
Cash | 8,490 | 11,781 | 24,057 | 14,244 |
Basic Shares | 231 | 126 | 118 | 42 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.53 |
2024-06-30 | -$3.62 |
2024-03-31 | -$0.85 |
2023-12-31 | -$0.85 |
